Literature DB >> 16956839

MLL/GAS7 fusion in a pediatric case of t(11;17)(q23;p13)-positive precursor B-cell acute lymphoblastic leukemia.

Ioannis Panagopoulos, Henrik Lilljebjörn, Bodil Strömbeck, Lars Hjorth, Tor Olofsson, Bertil Johansson.   

Abstract

MLL/GAS7, resulting from t(11;17)(q23;p13), has been reported in one case of treatment-related acute myeloid leukemia (AML). We present a de novo case of t(11;17)-positive pediatric acute lymphoblastic leukemia. Fluorescent in situ hybridization and reverse transcriptase polymerase chain reaction analyses revealed an MLL/GAS7 chimera identical to the one previously described in AML. The molecular genetic features of MLL/GAS7 and the clinical impact of t(11;17) are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16956839

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  2 in total

1.  A 6-gene signature identifies four molecular subgroups of neuroblastoma.

Authors:  Frida Abel; Daniel Dalevi; Maria Nethander; Rebecka Jörnsten; Katleen De Preter; Joëlle Vermeulen; Raymond Stallings; Per Kogner; John Maris; Staffan Nilsson
Journal:  Cancer Cell Int       Date:  2011-04-14       Impact factor: 5.722

2.  miR-362-5p promotes cell proliferation and cell cycle progression by targeting GAS7 in acute myeloid leukemia.

Authors:  Fuqun Wu; Changxin Yin; Junhua Qi; Deyu Duan; Xi Jiang; Jianhua Yu; Zhaofan Luo
Journal:  Hum Cell       Date:  2020-01-10       Impact factor: 4.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.